Health

Boston Scientific Completes CE Mark for EXALT™ Model B Single-Use Bronchoscope

Company to begin limited market release in Europe in June Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT™ Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the intensive care unit, operating room and bronchoscopy suite. Limited market release of the device is expected to […]

thaipr.net

25 พ.ค. 64

Lifebit Awarded A Four-Year Contract for Hong Kong’s Genome Project

Lifebit’s precision medicine software will power Hong Kong’s development of genomic medicine by supporting the Hong Kong Genome Institute to implement the first large-scale genome sequencing initiative, the Hong Kong Genome Project. The Project will empower medical professionals and researchers to leverage up to 50,000 whole genomes to achieve faster diagnosis, more precise and personalised […]

thaipr.net

25 พ.ค. 64

TricValve® Transcatheter Bicaval Valves System Receives CE Mark

OrbusNeich® Medical Company Ltd. and P&F Products & Features®, under the joint partnership OrbusNeich P&F, today announced that the TricValve® Transcatheter Bicaval Valves System has received CE mark approval. The TricValve® Transcatheter Bicaval Valve (bioprosthesis) is developed for the treatment of caval reflux present in cases of severe tricuspid regurgitation, without removal of the defective tricuspid […]

thaipr.net

20 พ.ค. 64

Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 in patients with mild COVID-19

Product recently cleared in EU as Class III medical device APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III […]

thaipr.net

13 พ.ค. 64

Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities

Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-weekly semaglutide 2.4 mg led to significant improvements in physical functioning, such as climbing stairs and tying your shoes, […]

thaipr.net

13 พ.ค. 64

Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate

– Manuscript highlights development of robust responses to both influenza and COVID-19 and protection against the SARS-CoV-2 virus – Data shared via preprint server for biology, bioRxiv, ahead of publication Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced data from a preclinical study of the company’s combination quadrivalent seasonal…

thaipr.net

11 พ.ค. 64
1 … 115 116 117 118 119 … 133

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.